Votre mission :

The team's objectives are to:
-    Develop new reagents and digital PCR assays to expand Stilla's offering or as service projects for customers.
-    Acquire knowledge, conduct proof-of-concept studies and publish application content on a variety of topics to showcase the full application potential of the naica® system. Application areas include oncology, cell and gene therapy, infectious diseases and many others.
-    Support and guide other companies or laboratories wishing to develop content or products for the naica® system.
-    Collaborate with the operations team to ensure the continuous improvement of Stilla® products.

The principal missions for the Senior Engineer R&D – Digital PCR Assay Development are:
-    Define, drive and manage digital PCR assay development projects required by a) the Stilla’s product development roadmap & b) our customer’s needs for assay development services.
-    Engage with customers to define assay development service projects, together with our Commercial team.
-    Manage external collaborations.
-    Ensure project advancement and documentation.
-    Come up with innovative ideas complementary to Stilla’s existing technologies & products; participate in the development of innovative Assay and Reagent products, ensure their troubleshooting and optimization.
-    Ensure the management of assistant engineers and engineers.
-    Ensure the timely advancement of priority projects by respecting key deadlines.
-    Write and complete all R&D procedures and V-cycle documents necessary for assay and reagent product development following the ISO13485 QMS, when required.
-    Stay up to date and transmit cutting edge digital PCR and genomics techniques and applications
-    Contribute to the generation and transmission of scientific content for the digital PCR Learning Center, Application notes and Technical notes.
-    Report regularly to management.
-    Respect the values of Stilla® Technologies.

Votre profil :

Has a M.Eng. / M.Sc. / PhD specializing in Molecular Biology, Biotechnology or a related discipline.
- Has at least 3 years of post-graduate technical experience in Assay & Reagent Development.
- Preferably, has at least 3 years of experience developing novel qPCR or digital PCR assays.
- Experience in personnel and project management would be appreciated.
- Must speak English and French.
- Has excellent communication and reporting skills and a strong ability to prioritize.
- Must be adaptable, organized, rigorous and results oriented. Skilled at multi-tasking and working flexibly around schedules in a fast-paced environment.
- Self-directed with strong initiative and an ability to work autonomously.
- Feels responsible for the advancement of projects, high data quality and meeting deadlines.
- Adept at working in a team with strong team spirit.
- Embraces high goals and a desire to contribute to technical innovations for the life sciences.
- Is passionate about genomics and healthcare.

A propos de Stilla Technologies :

Stilla Technologies is a Paris-area based \"tools for Life Sciences\" company that helps scientists to build the future of healthcare through high precision genetic analysis.
Since 2016, Stilla Technologies has been providing research organizations specialized in molecular biology and genetic analysis with its naica® System, a ground-breaking digital PCR solution that enables scientists to detect and quantify DNA mutations with unrivalled precision.
In November 2023, the company launched its latest instrument, the Nio™+, which integrates the entire digital PCR workflow into a single instrument, and features the best detection capacity on the market with its 7 imaging channels. With the naica® System and the Nio™+, researchers worldwide are developing a new generation of high-precision genetic tests, in various fields of applications such as liquid biopsy tests for cancer diagnostics, non-invasive prenatal testing or GMO detection.
Stilla Technologies is scaling its operations worldwide, with a focus on maintaining a strong R&D pipeline of innovative products for precision genetic analysis (instrumentation, consumables, software, assays and reagents) and commercializing RUO products.
Stilla Technologies’ talented and multidisciplinary team shares a passion for building successful Life Science and Diagnostic products based on deep technological innovations. We are pursuing a huge potential market and aim to become the new leader in the exciting field of precision genetic analysis. Today, Stilla is a pioneer in the development of highly multiplexed assays (>12-plex), thanks to cutting-edge design strategies and powerful fluorescence detection techniques.